These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2951170)

  • 21. Vitamin D analogue therapy, cardiovascular risk and kidney function in people with Type 1 diabetes mellitus and diabetic nephropathy: a randomized trial.
    Joergensen C; Tarnow L; Goetze JP; Rossing P
    Diabet Med; 2015 Mar; 32(3):374-81. PubMed ID: 25307511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prevention and protection in diabetic nephropathy].
    Lidén MK
    Lakartidningen; 2013 May 22-28; 110(21):1025-7. PubMed ID: 23805766
    [No Abstract]   [Full Text] [Related]  

  • 23. Natural history of diabetic nephropathy in non-insulin-dependent diabetes mellitus.
    Nelson RG; Knowler WC; Bennett PH
    J Diabet Complications; 1991; 5(2-3):76-8. PubMed ID: 1770058
    [No Abstract]   [Full Text] [Related]  

  • 24. The ratio between kidney volume and function increases with the progression of nephropathy in Type 2 diabetes.
    Giordano M; Ciarambino T; Gesuè L; Castellino P; De Simone M; Rinaldi G; D'Amora M; Zito G; Paolisso G; Coppola L
    Clin Nephrol; 2009 Oct; 72(4):247-51. PubMed ID: 19825329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glomerular charge selectivity in non-insulin-dependent diabetes mellitus.
    Chiba Y; Tani N; Yamazaki M; Nakamura H; Ito S; Shibata A
    J Diabet Complications; 1991; 5(2-3):135-7. PubMed ID: 1770022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-Alcoholic Fatty Liver Disease Is a Risk Factor for the Development of Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus.
    Jia G; Di F; Wang Q; Shao J; Gao L; Wang L; Li Q; Li N
    PLoS One; 2015; 10(11):e0142808. PubMed ID: 26566287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of antihypertensive treatment with indapamide in patients with noninsulin-dependent diabetes and persistent microalbuminuria.
    Gambardella S; Frontoni S; Grazia Felici M; Spallone V; Gargiulo P; Morano S; Menzinger G
    Am J Cardiol; 1990 May; 65(17):46H-50H. PubMed ID: 2330907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Practical problems in the management of hypertension in the diabetic patient.
    O'Hare JP
    J Diabetes Complications; 1996; 10(3):146-8. PubMed ID: 8807462
    [No Abstract]   [Full Text] [Related]  

  • 29. Controversies on the prevention of diabetic nephropathy.
    Chiarelli F; Verrotti A; Basciani F; di Ricco L; Sabatino G; Morgese G
    J Pediatr Endocrinol Metab; 1998 Apr; 11 Suppl 2():365-9. PubMed ID: 9642666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prediction, screening and treatment of renal complications of diabetes].
    Marre M; Larger E
    Rev Prat; 2001 Oct; 51(16):1769-75. PubMed ID: 11795120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adipokine zinc-alpha-2-glycoprotein as a novel urinary biomarker presents earlier than microalbuminuria in diabetic nephropathy.
    Wang Y; Li YM; Zhang S; Zhao JY; Liu CY
    J Int Med Res; 2016 Apr; 44(2):278-86. PubMed ID: 26857862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glomerular size- and charge selectivity in type 2 (non-insulin-dependent) diabetic patients with diabetic nephropathy.
    Gall MA; Rossing P; Kofoed-Enevoldsen A; Nielsen FS; Parving HH
    Diabetologia; 1994 Feb; 37(2):195-201. PubMed ID: 8163055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Residual proteinuria and eGFR predict progression of renal impairment within 2 years in type 2 diabetic patients with nephropathy who are receiving optimal treatment with angiotensin receptor blockers.
    Ivory SE; Packham DK; Reutens AT; Wolfe R; Rohde RD; Lewis J; Atkins RC;
    Nephrology (Carlton); 2013 Jul; 18(7):516-24. PubMed ID: 23506627
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical practice. Nephropathy in patients with type 2 diabetes.
    Remuzzi G; Schieppati A; Ruggenenti P
    N Engl J Med; 2002 Apr; 346(15):1145-51. PubMed ID: 11948275
    [No Abstract]   [Full Text] [Related]  

  • 35. Microalbuminuria in insulin-dependent diabetes--strategies to prevent diabetic nephropathy.
    Mathiesen ER
    Nephron; 1993; 65(4):511-21. PubMed ID: 8302402
    [No Abstract]   [Full Text] [Related]  

  • 36. [Diabetic nephropathy in type 2 diabetes--epidemiology, early diagnosis and therapeutic strategies].
    Schernthaner G
    Klin Wochenschr; 1992; 69 Suppl 29():28-34. PubMed ID: 1614188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal structure and function in type 2 diabetic patients with or without diabetic nephropathy.
    Christensen PK
    Dan Med Bull; 2004 Feb; 51(1):82-103. PubMed ID: 16009073
    [No Abstract]   [Full Text] [Related]  

  • 38. [Nephroprotection in patients with diabetes mellitus].
    Fischereder M
    MMW Fortschr Med; 2017 Sep; 159(15):60-62. PubMed ID: 28924706
    [No Abstract]   [Full Text] [Related]  

  • 39. The development of nephropathy in insulin-dependent diabetes mellitus is associated with poor glycemic control.
    Feldt-Rasmussen B
    Transplant Proc; 1994 Apr; 26(2):371-2. PubMed ID: 8171466
    [No Abstract]   [Full Text] [Related]  

  • 40. Salt restriction reduces hyperfiltration, renal enlargement, and albuminuria in experimental diabetes.
    Allen TJ; Waldron MJ; Casley D; Jerums G; Cooper ME
    Diabetes; 1997 Jan; 46(1):19-24. PubMed ID: 8971091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.